Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006

Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006–2015

Published:2018-11-10 Issue:2 Volume:299 Page:515-523
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Krugmann Jens^ORCID,Schwarz Corinna Lang,Melcher Balint,Sterlacci William,Ozalinskaite Agne,Lermann Johannes,Agaimy Abbas,Vieth Michael

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/article/10.1007/s00404-018-4952-9/fulltext.html

Reference63 articles.

1. Robert Koch Institut. Zentrum für Krebsregisterdaten (2017) Eierstockkrebs (Ovarialkarzinom). https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Ovarialkrebs/ovarialkrebs.html . Accessed 16 Mar 2018

2. Quirk JT, Natarajan N (2005) Ovarian cancer incidence in the United States, 1992–1999. Gynecol Oncol 97(2):519–523. https://doi.org/10.1016/j.ygyno.2005.02.007 (PMID:15863154)

3. Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053–1064. https://doi.org/10.2353/ajpath.2010.100105 (PMID:20651229)

4. Salani R, Bristow RE (2012) Surgical management of epithelial ovarian cancer. Clin Obstet Gynecol 55(1):75–95. https://doi.org/10.1097/GRF.0b013e31824b4629 (PMID:22343231)

5. Wright AA, Bohlke K, Edelson MI (2016) Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: Society of Gynecologic Oncology and ASCO clinical practice guideline summary. J Oncol Pract 12(12):1254–1257. https://doi.org/10.1200/JOP.2016.016873 (PMID:27624951)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-8 and WISP1 in the molecular characteristics of malignant ascites in ovarian cancer;Medical Immunology (Russia);2024-07-26

2. Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis;Chinese Chemical Letters;2024-07

3. Generation of a Specific Fluorescence In Situ Hybridization Test for the Detection of Ovarian Carcinoma Cells;Biomedicines;2024-05-24

4. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma;Scientific Reports;2024-03-30

5. Progress in the treatment of malignant ascites;Critical Reviews in Oncology/Hematology;2024-02